ADMA Biologics, Inc. (NASDAQ:ADMA) Director Young Kwon Purch

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) Director Young Kwon acquired 25,000 shares of ADMA Biologics stock in a transaction on Thursday, August 24th. The shares were bought at an average cost of $3.90 per share, for a total transaction of $97,500.00. Following the completion of the transaction, the director now owns 277,401 shares […]

Related Keywords

United States , Kyoung Kwon , Connor Clark Lunn Investment Management Ltd , Adma Biologics Inc , Securities Exchange Commission , Nasdaq , Biologics Company Profile , Cantor Fitzgerald , Capital Partners , Biologics Inc , Elevate Inc , Get Free Report , Director Young Kwon , Exchange Commission , Stock Down , Lunn Investment Management , Caligan Partners , Adma Biologics , Nasdaq Adma , Padma , Medical , Insider Trading , Nsider Trades , Stocks ,